| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/29/2023 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 09/29/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/27/2023 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
| 08/17/2023 |
4
| Horn Margaret A (COO) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Sold 3,085 shares
@ $30.3571, valued at
$93.7k
Sold 1,915 shares
@ $30.7993, valued at
$59k
Exercised 5,000 options to buy
@ $4.09, valued at
$20.5k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Sold 16,666 shares
@ $29.1913, valued at
$486.5k
Sold 16,666 shares
@ $32.4, valued at
$540k
|
|
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 08/01/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 08/01/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 08/01/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 08/01/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 08/01/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 7.1% stake in Revolution Medicines, Inc. |
| 06/16/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 6.8% stake in Revolution Medicines, Inc. |
| 06/12/2023 |
4
| Borellini Flavia (Director) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Granted 5,200 shares
@ $0
Granted 18,400 options to buy
@ $24.84, valued at
$457.1k
|
|
| 06/12/2023 |
4
| Borisy Alexis (Director) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Granted 5,200 shares
@ $0
Granted 18,400 options to buy
@ $24.84, valued at
$457.1k
|
|
| 06/12/2023 |
4
| Weber Barbara (Director) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Granted 5,200 shares
@ $0
Granted 18,400 options to buy
@ $24.84, valued at
$457.1k
|
|
| 06/12/2023 |
4
| ANDERSON ELIZABETH M (Director) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Granted 5,200 shares
@ $0
Granted 18,400 options to buy
@ $24.84, valued at
$457.1k
|
|
| 06/12/2023 |
4
| SCHMIDT ERIC THOMAS (Director) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Granted 5,200 shares
@ $0
Granted 18,400 options to buy
@ $24.84, valued at
$457.1k
|
|
| 06/12/2023 |
4
| Patel Sushil (Director) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Granted 5,200 shares
@ $0
Granted 18,400 options to buy
@ $24.84, valued at
$457.1k
|
|
|